MENZO, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 5.958
EU - Europa 3.058
AS - Asia 2.474
SA - Sud America 473
AF - Africa 153
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 3
Totale 12.127
Nazione #
US - Stati Uniti d'America 5.852
SG - Singapore 829
IT - Italia 547
RU - Federazione Russa 518
VN - Vietnam 506
UA - Ucraina 473
BR - Brasile 370
CN - Cina 368
DE - Germania 297
IE - Irlanda 282
HK - Hong Kong 242
SE - Svezia 204
FR - Francia 180
DK - Danimarca 171
FI - Finlandia 136
TR - Turchia 127
GB - Regno Unito 120
KR - Corea 96
BD - Bangladesh 74
CI - Costa d'Avorio 69
IN - India 62
CA - Canada 50
MX - Messico 40
AR - Argentina 38
NL - Olanda 31
IQ - Iraq 27
ZA - Sudafrica 27
MA - Marocco 24
AT - Austria 22
PL - Polonia 22
ID - Indonesia 20
BE - Belgio 16
CO - Colombia 16
VE - Venezuela 15
PK - Pakistan 14
JP - Giappone 13
UZ - Uzbekistan 13
ES - Italia 12
PH - Filippine 12
SA - Arabia Saudita 12
EC - Ecuador 9
CL - Cile 7
DZ - Algeria 7
NP - Nepal 7
MY - Malesia 6
PE - Perù 6
AE - Emirati Arabi Uniti 5
BO - Bolivia 5
EU - Europa 5
JO - Giordania 5
KE - Kenya 5
LT - Lituania 5
PA - Panama 5
RO - Romania 5
TN - Tunisia 5
IL - Israele 4
PY - Paraguay 4
AZ - Azerbaigian 3
CM - Camerun 3
CR - Costa Rica 3
EG - Egitto 3
OM - Oman 3
SN - Senegal 3
TH - Thailandia 3
TW - Taiwan 3
UY - Uruguay 3
A1 - Anonimo 2
AO - Angola 2
BH - Bahrain 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
HN - Honduras 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LK - Sri Lanka 2
MK - Macedonia 2
MN - Mongolia 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
Totale 12.118
Città #
Ashburn 815
Singapore 487
Jacksonville 479
Chandler 441
Fairfield 376
Des Moines 303
San Jose 288
Dublin 282
Dallas 254
Boardman 249
Hong Kong 228
Wilmington 190
Woodbridge 166
Houston 159
New York 155
Ho Chi Minh City 145
Seattle 144
Ann Arbor 119
The Dalles 116
Hanoi 108
Lawrence 107
Princeton 107
San Mateo 107
Cambridge 100
Lauterbourg 96
Los Angeles 96
Moscow 77
Redmond 70
Abidjan 69
Beijing 68
Hefei 62
Ancona 56
San Diego 52
Milan 51
Buffalo 46
Civitanova Marche 39
Munich 39
Helsinki 37
London 36
Centro 35
Chicago 35
Da Nang 32
São Paulo 29
Orem 28
Council Bluffs 27
Rome 24
Santa Clara 21
Turin 20
Montreal 19
Warsaw 19
Nuremberg 17
Shanghai 17
Brussels 16
Chennai 16
Marche 16
Mexico City 16
Haiphong 15
Johannesburg 15
Miano 15
Wuhan 14
Guangzhou 13
Manchester 13
Rio de Janeiro 13
Tashkent 12
Washington 12
Appignano 11
Baghdad 11
Frankfurt am Main 11
Amsterdam 10
Ankara 10
Brooklyn 10
Hanover 10
Norwalk 10
Turku 10
Ninh Bình 9
Toronto 9
Boston 8
Denver 8
Pune 8
Stockholm 8
Tokyo 8
Can Tho 7
Cingoli 7
Falls Church 7
Goiânia 7
Hải Dương 7
Porto Alegre 7
Quận Một 7
Vienna 7
Atlanta 6
Bari 6
Belo Horizonte 6
Biên Hòa 6
Cape Town 6
Columbus 6
Delhi 6
Dhaka 6
Fayetteville 6
Hortolândia 6
Istanbul 6
Totale 7.601
Nome #
Antimicrobial Resistance: A Challenge for the Future 303
Molecular tracing of SARS-CoV-2 in Italy in the first three months of the epidemic 212
A clone of linezolid-resistant Staphylococcus epidermidis bearing the G2576T mutation is endemic in an Italian hospital 206
Evaluation of the Ion AmpliSeq SARS-CoV-2 Research Panel by Massive Parallel Sequencing 199
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 195
SARS-CoV-2 multi-variant rapid detector based on graphene transistor functionalized with an engineered dimeric ACE2 receptor 179
Quantification of the HIV-1 total reservoir in the peripheral blood of naïve and treated patients by a standardised method derived from a commercial HIV-1 RNA quantification assay. 166
Trend of clinical vancomycin-resistant enterococci isolated in a regional Italian hospital from 2001 to 2018 165
Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction. 163
High prevalence of carbapenem-resistant Klebsiella pneumoniae ST307 recovered from faecal samples in an Italian hospital 153
Distribution and molecular analysis of mef(A)-containing elements in tetracycline-susceptible and -resistant Streptococcus pyogenes clinical isolates with efflux-mediated erythromycin resistance. 150
Increase and diversity of carbapenemase-producing Escherichia coli isolates, Italy 149
Visceral fat inflammation and fat embolism are associated with lung's lipidic hyaline membranes in subjects with COVID-19 147
Competitive polymerase chain reaction and analysis of viral activity at the molecular level. 143
Dynamics of molecular parameters of human immunodeficiency virus type 1 activity in vivo. 143
Analysis of the functional relationship between V3 loop and gp120 context with regard to human immunodeficiency virus coreceptor usage using naturally selected sequences and different viral backbones. 141
Hepatitis E in a region of Italy: An emerging autochthonous infection? 141
Tocilizumab in COVID-19 interstitial pneumonia 138
A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen. 137
A single-step DNA extraction procedure for the detection of serum hepatitis B virus sequences by the polymerase chain reaction. 136
Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS. 136
Phylogeography and genomic epidemiology of SARS-CoV-2 in Italy and Europe with newly characterized Italian genomes between February-June 2020 135
POOR RESPONSE TO FIRST BNT162B2 SARS-COV-2 VACCINE DOSE IN RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT 134
Molecular epidemiology and pathogenetic potential of underdiagnosed human papillomavirus types. 130
Host-specific modulation of the selective constraints driving human immunodeficiency virus type 1 env gene evolution. 129
Clinicopathological features of primary cutaneous B-cell lymphomas from an academic regional hospital in central Italy: no evidence of Borrelia burgdorferi association 129
Autochthonous dengue outbreak in Marche Region, Central Italy, August to October 2024 128
Molecular epidemiology and pathogenic potential of underdiagnosed human papillomavirus types 125
Genotypic and phenotypic correlates of the HIV Type 1 env gene evolution in infected children with discordant response to antiretroviral therapy. 122
Analisi della regione tet(O)-mef(A) in un elemento orf3-negativo di Streptococcus pyogenes. 122
Locally acquired hepatitis E virus in Marche Italy: Clinical/laboratory features and outcome 122
First Detection of SARS-CoV-2 by Real-Time Reverse Transcriptase-Polymerase Chain Reaction Assay in Pleural Fluid 121
Adeno-associated virus type 5 infection via PDGFRα is associated with Interstitial lung disease in systemic sclerosis and generates composite peptides and epitopes recognized by the agonistic immunoglobulins present in patients with systemic sclerosis 116
Declining prevalence of HIV-1 drug resistance in antiretroviral treatment-exposed individuals in Western Europe. 115
Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically. 114
Detection of human immunodeficiency virus type 1 genomic RNA in plasma samples by reverse-transcription polymerase chain reaction. 113
Trans-activation of epidermal growth factor receptor gene by the hepatitis B virus X-gene product. 111
Quantitative PCR and RT-PCR in virology. 111
Prophylaxis of HCV reinfection and direct-acting antiviral agents during liver transplantation 110
Quantitative molecular methods in virology. 109
A large epidemic of hepatitis B in Serbia: an integrated model for outbreak investigations in healthcare settings 109
Vaginal micropapillary lesions are not related to human papillomavirus infection: in situ hybridization and polymerase chain reaction detection techniques 109
Local Epidemics Gone Viral: Evolution and Diffusion of the Italian HIV-1 Recombinant Form CRF60_BC 108
Processivity and drug-dependence of HIV-1 protease: determinants of viral fitness in variants resistant to protease inhibitors. 106
Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy. 106
Resistance and replicative capacity of HIV-1 strains selected in vivo by long-term enfuvirtide treatment. 106
Insulin-like growth factor 1 expression correlates with clinical outcome in K-RAS wild type colorectal cancer patients treated with cetuximab and irinotecan 104
A novel procedure for quantitative polymerase chain reaction by coamplification of competitive templates. 104
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021 104
Eritromicino-resistenza da efflusso in ceppi tetraciclino-sensibili (Tcs) e tetraciclino-resistenti (Tcr) di Streptococcus pyogenes. 103
Human case of autochthonous West Nile virus lineage 2 infection in Italy, September 2011. 102
42. Adenoviridae 101
A human binding site for transcription factor USF/MLTF mimics the negative regulatory element of human immunodeficiency virus type 1. 101
Quantitative evaluation of the recombinant HIV-1 phenotype to protease inhibitors by a single-step strategy. 100
Absence of HHV-6 and HHV-7 in cerebrospinal fluid in relapsing-remitting multiple sclerosis. 100
Weak cross-lineage neutralization by anti sars-cov-2 spike antibodies after natural infection or vaccination is rescued by repeated immunological stimulation 97
A statistical model based on serological parameters for predicting occult HBV infection: implications for organ/ blood donations 96
Genotype and phenotype patterns of human immunodeficiency virus type 1 resistance to enfuvirtide during long-term treatment. 96
Rare mutations in a domain crucial for V3-loop structure prevail in replicating HIV from long-term non-progressors. 95
Sequence analysis of the hepatitis B virus pre-C region in hepatocellular carcinoma [HCC] and nontumoral liver tissues from HCC patients. 95
Clearance of HIV-1 viraemia after seroconversion. 95
The role of human papillomavirus DNAs in cervical carcinoma and risk of lymph node metastasis: association with 72-kilodalton metalloproteinase immunostaining 94
Serological response after anti-SARS-CoV-2 BNT162b2 vaccine in IBD patients on biological therapy: a monocentric case-control study 93
HPV DNA positivity and natural killer cell activity in the clinical outcome of mild cervical dysplasia: integration between virus and immune system 93
Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting. 91
Cluster analysis of antibiotic susceptibility patterns of clinical isolates as a tool in nosocomial infection surveillance. 91
Evolutionary trends of resistance mutational patterns of HBV reverse transcriptase over years (2002–2012) of different treatment regimens: The legacy of lamivudine/adefovir combination treatment 91
Human papillomavirus infections: new perspectives for prevention and treatment. 88
Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 (HIV-1) infection 87
Comparison of HIV-1 recombinant phenotypic assays and virtual phenotype in the definition of coreceptor usage 87
Low-abundance drug resistance mutations: extending the HIV paradigm to hepatitis B virus. 86
Long-term follow-up of acute hepatitis B: New insights in its natural history and implications for antiviral treatment 86
Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo 85
Competitive polymerase chain reaction for quantitating feline immunodeficiency virus load in infected cat tissues. 85
Immune response, rather than sensitivity to entecavir, may determine the rate of viral decay upon treatment initiation in patients with chronic HBV infection 84
Inhibition of R5X4 dualtropic HIV-1 primary isolates by single chemokine co-receptor ligands. 84
Simple and reliable method to quantify the hepatitis B viral load and replicative capacity in liver tissue and blood leukocytes 84
Italian Patent with european extension: New molecular vector for the geno-phenotypic characteristics of V3 sequences of the HIV gp120. 83
Frequency and treatment-related predictors of thymidine-analogue mutation patterns in HIV-1 isolates after unsuccessful antiretroviral therapy. 83
Surgery and topic cidofovir for nasal squamous papillomatosis in HIV+ patient. 82
Slow response to entecavir treatment in treatment-naive HBV patients is conditioned by immune response rather than by the presence or selection of refractory variants 82
Molecular and cellular determinants of cell-to-cell transmission of HCV in vitro. 81
Evolutionary pattern of pandemic influenza (H1N1) 2009 virus in the late phases of the 2009 pandemic. 81
European Patent n° EPO 99830776.3: Method to evaluate the HIV drug sensitivity 80
Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. 80
Immune reconstitution in HIV-1 infected children with discordant response to antiretroviral therapies: patterns of HIV-1 env gene evolution driven by restoration of thymic function. 79
Prone Positioning and Intravenous Zanamivir may Represent Effective Alternatives for Patients with Severe ARDS Virus A (H1N1) Related Pneumonia in Hospitals with no Access to ECMO. 79
Lack of Chlamydia infection of the central nervous system in multiple sclerosis. 79
Insulin-like growth factor 1 (IGF-1) expression correlates with clinical outcome in K-RAS wild type colorectal cancer patients treated with cetuximab-irinotecan. 77
Intra-host evolution of human immunodeficiency virus type 1 and viral fitness. 77
The introduction of the fusion inhibitors in the HAART-regimens. 76
Quantitation of hepatitis C virus genome molecules in plasma samples. 76
Human immunodeficiency virus type 1 and hepatitis B virus transcription in peripheral blood lymphocytes from co-infected subjects. 76
Epidemiological impact of human adenovirus as causative agent of respiratory infections: An Italian multicentre retrospective study, 2022-2023 75
No pol mutation is associated independently with the lack of immune recovery in patients infected with HIV and failing antiretroviral therapy. 75
HIV-1 replication capacity and genotype changes in patients undergoing treatment interruption or lamivudine monotherapy. 75
Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study). 74
Detection of human immunodeficiency virus type 1 transcripts in peripheral blood lymphocytes by the polymerase chain reaction. 74
Viral dynamics and mutations in the pol gene during primary HIV-1 infection. 73
Hepatitis B virus preC mutants in human hepatocellular carcinoma tissues. 73
Totale 11.134
Categoria #
all - tutte 58.410
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.410


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202163 0 0 0 0 0 0 0 0 0 0 0 63
2021/2022882 83 211 13 24 10 53 56 58 67 58 68 181
2022/20231.545 136 116 124 113 117 393 10 72 330 6 99 29
2023/2024820 134 16 50 118 167 151 8 40 13 13 17 93
2024/20251.725 205 149 84 10 55 50 175 67 472 132 145 181
2025/20264.381 276 278 236 390 458 310 858 455 374 411 165 170
Totale 12.264